Send to a friend
Fill in the form below and click on the "send" button to e-mail a link to this content.
You can send to UP TO FIVE e-mail addresses by separating them with commas.
Amsterdam/Cologne, International —
A German law court in Cologne/Germany today ordered biotechnology giant Monsanto to make one of it's confidential reports public after the company tried to prevent the dissemination of its own study. The 1000-page document is in the center of international attention after its results were exposed by the British newspaper Independent On Sunday (1).
Greenpeace have asked for access to the document in Germany referring
to an EU-law which states that the public has the right to have insight
in all documents related to risk assessement of genetically modified
(GM) plants. After the German state authorities endorsed the access,
Monsanto filed a court case against the government of Germany in an
attempt to try to stymie the publishing of the document. Greenpeace
joined sides with the German government in the case and with today's
order the original study should be open for insight by the public.
"This is a important success - both for Greenpeace and for the people.
The strategy of secrecy and intransparency of Monsanto failed, and now
the document can be a subject to independent investigations," said
Greenpeace International campaigner Christoph Then.
The aforesaid rat feeding study found "significant" effects in the
blood and organs of the rats fed on the GM maize MON863. A number of
scientists across Europe who have already seen the study expressed
concerns about the health and safety implications of this GM corn.
Monsanto does not put in question that there were significant health
effects in the rats, but claims that these were not caused by the GM
maize. But according to the opinion of several experts the explanations
of Monsanto are not sufficient to put down recent concerns.
On the 24th of June the Council of EU ministers will decide on the
market authorisation for import and use of MON863 in our food. It is
almost impossible to evaluate Monsanto's over 1000-page study on the
health effects until that date; in particular because Monsanto is
expected to file a further appeal against the recent decision, which
could result in further delay in the publication of the documents.
"EU member states should set a clear signal in the interest of their
people and should reject the application of the GM maize. Otherwise the
maize corn could be permitted by the EU Commission without any further
consultation or votings - and that could have serious consequences," -
said Then.
Notes to Editor
(1) Independent On Sunday, 22 April 2005.